Anti-CD96 Neutralizing Antibody

Anti-CD96 Neutralizing Antibody
Artikelnummer
BPS102141-2
Verpackungseinheit
100 µg
Hersteller
BPS Bioscience

Verfügbarkeit: wird geladen...
Preis wird geladen...

Quote the promo code SZANTIBODY when ordering to receive a 10% discount on this antibody, from October 1st to December 31st 2024. No additional discounts during the promo.



Products from BPS Bioscience require a minimum order value above 400€

Application: Useful for studying the binding and neutralization of CD96 in ELISA and in cellular assays.

Assay Conditions: The neutralizing activity of Anti-CD96 Neutralizing Antibody (BPS Bioscience #102141) was measured using CD155:CD96[Biotinylated] Inhibitor Screening Chemiluminescence Assay Kit (BPS Bioscience #82532)

Background: CD96, also known as Tactile (T cell activation, increased late expression), is an immune checkpoint receptor of the immunoglobulin superfamily of proteins found in T and NK cells. Other proteins of the same superfamily include CD226 (also known as DNAM-1) and TIGIT (T cell immunoglobulin and ITM domain), with CD96 and TIGIT acting as inhibitory receptors and CD226 as a co-stimulatory receptor. CD96 binds to CD155, competing with CD226. CD96 plays a role in NK-cell adhesion to target cells, inhibiting NK cell cytokine release. It also plays an inhibitory role in Th9 cells and is a cancer stem cell marker. An imbalance in CD155/CD96 and CD155/CD226 can lead to lack of or to excessive immune responses. In LUAD (lung adenocarcinoma) the levels of CD96 in CD8+ T cells are elevated compared to healthy individuals, possibly promoting a hypo-immune response. CD96, together with TIGIT, has become a widely researched target in immunotherapy, and blockage of CD96 binding to CD155 combined with other therapies, such as anti-PD-1 (programmed death protein 1) or doxorubicin chemotherapy, has shown great promise. The development of strategies to block CD96 inhibitory immune responses will continue to be an active area de research, opening new avenues of treatment for cancer patients.

Description: This anti-CD96 antibody is a purified, recombinant monoclonal antibody that recognizes human CD96. This antibody has been tested for neutralization of CD96 interaction with CD155 in a binding assay. 

Format: Aqueous buffer solution.

Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

Purity: ≥90%

Storage Stability: At least 12 months at -80°C.

Uniprot: P40200

Warnings: Avoid freeze/thaw cycles

Biosafety Level: Not applicable (BSL-1)
Mehr Informationen
Artikelnummer BPS102141-2
Hersteller BPS Bioscience
Hersteller Artikelnummer 102141-2
Verpackungseinheit 100 µg
Mengeneinheit STK
Klonalität Monoclonal
Methode ELISA
Isotyp IgG1
Wirt Human
Konjugat Unconjugated
Produktinformation (PDF) Download
MSDS (PDF)
×